Growth measurements in Ugandan children with sickle cell anaemia from a hydroxyurea (hydroxycarbamide) treatment trial relative to unaffected sibling controls
British Journal of Haematology · 2025
DOI: 10.1111/bjh.70164 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Dennis Kalibbala und 17 weiteren Autor:innen. Beteiligte Einrichtung: Global Health Uganda, Kampala, Uganda. Hauptthemen laut MEDLINE: Hydroxyurea, Anemia, Sickle Cell, Antisickling Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, Fogarty International Centre at the National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development and the Fogarty International Center, both of the National Institutes of Health….
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Children with sickle cell anaemia (SCA) in sub‐Saharan Africa (SSA) frequently experience impaired growth. Hydroxyurea (hydroxycarbamide) improves growth in higher resourced countries, but its effects on growth and body composition have not been evaluated in SSA. In an open‐label, single‐arm, 30‐month dose‐escalated hydroxyurea trial in Ugandan children aged 3 to
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Global Health Uganda, Kampala, Uganda.
- Child Health and Development Centre, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
- Department of Pediatrics and Child Health, Makerere University College of Health Sciences, Kampala, Uganda.
- Mulago Hospital, Kampala, Uganda.
- Department of Epidemiology and Biostatistics, Makerere University School of Public Health, Kampala, Uganda.
- Department of Psychiatry, Makerere University College of Health Sciences, Kampala, Uganda.
ORCID-Profile: Nancy S Green
Förderung
- NICHD NIH HHS
- Fogarty International Centre at the National Institutes of Health (NIH)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development and the Fogarty International Center, both of the National Institutes of Health…
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
Zitieren
APA
Kalibbala, D., Mboizi, V., Nambatya, G., Murungi, S., Ashaba, J., Nabaggala, C., Turyagyenda, L., Munube, D., Kasirye, P., Wambaka, B., Mpungu, A., Ssenkusu, J. M., Namazzi, R., Bangirana, P., Opoka, R. O., Mupere, E., Idro, R., & Green, N. S. (2025). Growth measurements in Ugandan children with sickle cell anaemia from a hydroxyurea (hydroxycarbamide) treatment trial relative to unaffected sibling controls. British Journal of Haematology. https://doi.org/10.1111/bjh.70164
Vancouver
Kalibbala D, Mboizi V, Nambatya G, Murungi S, Ashaba J, Nabaggala C, et al. Growth measurements in Ugandan children with sickle cell anaemia from a hydroxyurea (hydroxycarbamide) treatment trial relative to unaffected sibling controls. British Journal of Haematology. 2025. doi:10.1111/bjh.70164
BibTeX
@article{Kalibbala2025,
author = {Kalibbala, Dennis and Mboizi, Vincent and Nambatya, Grace and Murungi, Susan and Ashaba, Joan and Nabaggala, Catherine and Turyagyenda, Lynnth and Munube, Deogratias and Kasirye, Phillip and Wambaka, Bill and Mpungu, Amiirah and Ssenkusu, John M and Namazzi, Ruth and Bangirana, Paul and Opoka, Robert O and Mupere, Ezekiel and Idro, Richard and Green, Nancy S},
title = {Growth measurements in Ugandan children with sickle cell anaemia from a hydroxyurea (hydroxycarbamide) treatment trial relative to unaffected sibling controls},
journal = {British Journal of Haematology},
year = {2025},
doi = {10.1111/bjh.70164}
}
EUVIMED